Instructions
Please read this page carefully. You will need to scroll down this page and ensure that you have read the learning objectives, accreditation information, and potential conflicts of interest disclosures for the authoring faculty. Please check the box to agree to the terms of understanding and click the "Start Module" button on the bottom of the page to begin your learning activity.

Learning Objectives
After completing this educational activity, the learner should be better able to:

• Recognize the importance of treating patients with CML who experience a suboptimal response according to current practice guidelines;
• Identify patients with CML who have a suboptimal response to treatment;
• Formulate an alternative treatment plan for patients whose first-line therapy has failed or who have had a suboptimal response to first-line therapy.

Accreditation
This learning activity has expired however you may still review module content.

Target Audience
This learning activity is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat chronic myelogenous leukemia in the hematology/oncology and transplant patient settings.

Disclosure Statements
To view the Disclosure Statements, please click here.